The Transplantation Society is a non-profit NGO providing global leadership in transplantation. Our core mission include the development of the science and clinical practice, scientific communication, continuing education and guidance on the ethical practice.

Subscribe to Tribune PulseView PAST ISSUES

march14

THE TTS 2019 1ST REGIONAL MEETING ... a great success

 

The 350+ participants of our 1st TTS Regional Meeting enjoyed this great opportunity to discuss Deceased Donation in the Middle East with important Key Opinion Leaders from across the world. We will be publishing the highlights of the meeting in upcoming issues of the Tribune Pulse as well as the upcoming quarterly Tribune newsletter.

UPDATE: The presentation recordings will be made available to TTS Members by tHE end of April. Stay Tuned for updates.

Just Released - Transplantation Direct - April Issue

The April issue of Transplantation Direct offers interesting articles on a number of topics for clinicians and scientists. Among the topics covered are age-related issues with regard to gene expression patterns in kidney transplant recipients and selection of donor-recipient combinations in liver transplantation. We have articles on using alternative endpoints to determine allograft function and on a safety/efficacy trial of prolonged-release tacrolimus exposure in the Asian population; both of these studies are in kidney transplantation. In experimental pig and mouse models we publish studies on the impact of specific perfusates during normothermic liver perfusion under DCD conditions and on the effects of complement on the glycocalyx related to ischemia-reperfusion injury, respectively. Please have a look these articles, as well as others that appear in this current issue of Transplantation Direct.

CLICK HERE TO ACCESS THIS Open Access  ISSUE

TTS New Webinar Series

EC Liver Series v2

The Education Committee of TTS will be continuing its webinar series on the "Trends and Challenges in Liver Transplantation."

TOPIC: Acute Liver Failure
TITLE: Medical and Surgical Aspects of Acute Liver Failure
Wednesday, April 24, 2019 - 3:00 PM EDT (Montreal time)

sukru Organizer and Moderator: Sukru Emre, MD
Professor of Surgery (Transplant) and of Pediatrics, Yale University
New Haven, CT, USA
Manuel Rodriguez-Davalos Discussant: Manuel Rodriguez-Davalos, MD, FACS
Transplant and Hepatobiliary Surgery
Primary Children's Hospital - Intermountain Medical Center
Salt Lake City, UT, USA
Jody C. Olson

Discussant: Jody C. Olson, MD, FACP
Associate Professor of Medicine
University of Kansas Medical Center
Kansas City, KS, USA

Click here to signup

Save the Date - CAST 2019
Delhi - SepTMBER  29 - OctOBER 2

The 16th Congress of the Asian Society of Transplantation (CAST 2019) will be held from 29th Sep – 2nd Oct 2019 at India Exposition Mart Limited (IEML) Greater Noida (Delhi/NCR), India. The conference will bring together international and national faculties who will share their knowledge and expertise in the field of organ transplantation. More than 2000 national and interational delegates are expected to attend. We look forward to your active participation in CAST 2019 and hope you will enjoy the ancient city of Delhi.

CAT 2019

VISIT http://cast2019.in FOR FULL DETAILS

IPTA 2019 - May 4-7, 2019 - Vancouver, Canada

The International Pediatric Transplant Association has put together an amazing program for their upcoming meeting in early May featuring world-renowned speakers. Please visit the website www.ipta2019.org for full details. Vancouver is a beautiful and unique destination and we hope that as many TTS and Section members will participate in this important meeting. 

ipta2019

 

VISIT HTTP://IPTA2019.ORG FOR FULL DETAILS

TRANSPLANTATION DIRECT - HIGHLIGHTED ARTICLE

Dr. Peri Husen, Editorial Fellow, Transplantation

Significant Hyperfibrinolysis in a Patient With Intracardiac Thrombosis to Give Antifibrinolytics or Not?.

Simon, Eric R., MD1; Darling, Christopher D., DO1; Hammel, Laura L., MD1.
Transplantation Direct: March 2019 - Volume 5 - Issue 3 - p e431 doi: 10.1097/TXD.0000000000000875

In this case report, Simon and coworkers describe an interesting case of a liver transplant recipient who suffered an intracardiac thrombosis (ICT) shortly after reperfusion of the graft. After it resolved, the patient developed severe hyperfibrinolysis and massive hemorrhage, which was ultimately successfully treated using an antifibrinolytic agent. The challenge of treating a patient that suffers both an ICT and significant nonsurgical bleeding is discussed in depth, highlighting the fact that the balance of both procoagulant and anticoagulant factors in the setting of end-stage liver disease and liver transplantation can easily be tipped toward hyperfibrinolysis, increasing the risk of hemorrhage, or hypofibrinolysis, increasing the risk of thrombosis.

CLICK TO READ THIS OPEN ACCESS ARTICLE

TRANSPLANTATION - WEEK'S MOST DOWNLOADED PAPER

Tweet.2

CLICK TO READ THIS ARTICLE

In the News

Hepatitis C Not A Barrier For Organ Transplantation, Study Finds

April 3 - Donated organs from people who were infected with the hepatitis C virus can be safely transplanted, according to the latest in a line of studies that are building a case for using these organs. Typically, these organs have been discarded because of concerns about spreading the viral infection. But a study of heart and lung transplants published by the New England Journal of Medicine finds that new antiviral drugs are so effective that the recipients can be protected from infection.

READ THE FULL ARTICLE


Live donor liver offers improve transplant survival in patients with HCC

April 2 - Patients with hepatocellular carcinoma who had a potential live donor at listing for liver transplantation had a significantly lower risk for mortality compared with those who waited for a deceased donor graft, according to recently published data. According to Nicolas Goldaracena, MD, from the University of Toronto in Canada, and colleagues, the benefits derived from live donor liver transplantation (LDLT) related to a lower dropout rate and shorter waiting period.
(hint: if you have trouble accessing this article, try to access in a "private window" or "incognitio mode" using the link below)

READ THE FULL ARTICLE


Removal of 'zombie cells' alleviates causes of diabetes in obese mice

March 25, 2019 - Researchers have shown that when senescent cells -- also known as 'zombie cells' -- are removed from fat tissue in obese mice, severity of diabetes and a range of its causes or consequences decline or disappear.

READ THE FULL ARTICLE

'Excellent' heart transplant outcomes observed from donors with circulatory death

April 1 - A new report from Australia highlights the feasibility of transplanting hearts from donors who have experienced circulatory death—a practice which, if adopted, could expand heart transplant volume by an estimated 20 percent.

READ THE FULL ARTICLE


Transplantation of bone marrow-derived EPCs slows ALS disease progression

April 3 - Transplantation of human bone marrow-derived endothelial progenitor cells (EPCs) into mice mimicking symptoms of amyotrophic lateral sclerosis (ALS) helped more motor neurons survive and slowed disease progression by repairing damage to the blood-spinal cord barrier (BSCB), University of South Florida researchers report. The new study, published March 27 in Scientific Reports, contributes to a growing body of work exploring cell therapy approaches to barrier repair in ALS and other neurodegenerative diseases.

READ THE FULL ARTICLE


EU-funded researchers develop 'nano-vehicle' to deliver life-saving drugs

April 1 - The NABBA project has developed nano-vehicles based on different auto-assembling molecules of natural and synthetic origin, such as liposomes and certain polysaccharides. Researchers designed the vehicles to be invisible to the immune system and equipped them to overcome the biological barriers while delivering a useful amount of drug to the right place in a controlled manner.

READ THE FULL ARTICLE


UC San Diego Health Treats 1st Cancer Patient with Stem-Cell Derived Natural Killer Cells

April 1 - Fate Therapeutics, in collaboration with UC San Diego researcher, developed first off-the-shelf immunotherapy from human induced pluripotent stem cells that is now in clinical trials.

READ THE FULL ARTICLE


Rare double-organ transplant conducted at Israeli children's hospital

March 31 - In addition to the difficulty involved within a double-organ transplant, doctors also said that they found the donor's internal organs in "reverse order" from normal positioning.

READ THE FULL ARTICLE



Upcoming Meetings and ANNOUNCEMENTS

IPITA 2019 LYON - France

Registration is open and preliminary program are both available.

CLICK TO VISIT IPITA2019.ORG

IXA 2019 - Abstract Submission Now Open!

slider1 71248411

VISIT WWW.IXA2019.ORG FOR FULL DETAILS

2019 TTS TRansplantation Science COmmittee NEWS 

Hold the Date - November 10-13, 2019

ITS 2019 is set for Nov. 10-13 in Clearwater Beach, Florida. Keynote speakers include Katherine High, President and Head of R&D at Spark Therapeutics, and Ronald Germain, chief of Laboratory of Immune System Biology and Lymphocyte Biology Section at the National Institute of Allergy and Infectious Diseases National Institutes of Health.

CIRTA2019 2

CTRMS 2019 – Lesvos - Greece

CIRTA2019 2

CLICK TO GO TO THE CTRMS 2019 WEBSITE

ISODP 2019 - Dubai, UAE - Program Update

isodp2019

VISIT WWW.ISODP2019.ORG FOR FULL DETAILS

TID2019 - SAVE THE DATES!
PrE-MEETING TO ISODP 2019 - SAME VENUE ...one day prior!

1tid

VISIT WWW.TID2019.ORG FOR FULL DETAILS

Official Sections of The Transplantation Society

cts
isodp new logo v7